PRF Technologies Reports Expanded Preclinical Results for PRF-110 in Head-to-Head Comparison with Approved Benchmark

Go back to PRF Technologies Reports Expanded Preclinical Results for PRF-110 in Head-to-Head Comparison with Approved Benchmark
(NASDAQ: PRFX) Delayed: 1.15 -0.05 (4.17%)
Previous Close $1.20    52 Week High
Open $1.20    52 Week Low
Day High $1.20    P/E N/A 
Day Low $1.13    EPS
Volume 85,380